Developer docs
API playgroundTry for free, no card

Search company profiles

INNOV LABS

Full company profile

uuid003pu65

Namestring
INNOV LABS
Legal namestring
Innov Labs
Websiteurl
innovlabs.ai
Company typeenum
Private
Founded yearint
2024
Descriptiontext

INNOV LABS is a privately-held AI drug discovery and pharmaceutical R&D technology company headquartered in Houston, Texas, with a secondary office in Hyderabad, India, operating through US entity Innov Labs (Texas) and India entity Innov Labs India (Telangana). The company builds an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis, and automated reporting, powered by domain-tuned Graph Neural Networks and Transformers for multi-omics analysis, predictive modeling, hit-to-lead identification, and ADMET prediction. The platform supports genomics, proteomics, chemistry, and clinical data, with NLP over biomedical literature, computer vision for high-content screening and Cryo-EM, and explainable AI for biological interpretability, all delivered on a cloud-native architecture spanning Azure, AWS, and GCP with deployment options including dedicated VPC and on-premises.

The product portfolio is organized as a unified stack: the AI Platform for Scientific Data Analysis and Reporting, the ELN, the Biological Data Analysis Engine, and Scientific Reporting and Insights. Complementary service lines include Chemical R&D, Biotech and Life Sciences, Drug Discovery and Development, Clinical Trial Scientific Services, and ML and AI Solutions, delivered through fractional scientist retainers, project-based engagements, embedded scientific teams, and expert advisory models. The company maintains HIPAA, GDPR, ISO, and 21 CFR Part 11 compliance, is pursuing AICPA SOC 2 Type 2, and is a member of the NVIDIA Inception Program.

Commercially, INNOV LABS operates a hybrid go-to-market with a sales-led enterprise motion (Request a Demo, Schedule Demo Session, Contact Sales) for pharma, biotech, and healthcare buyers, alongside a product-led growth motion offering a free trial with no credit card required. Pricing is tiered across Research Teams, Growth and Innovation, and Enterprise subscriptions, with billing on monthly, annual, and multi-year cadences; pricing is not publicly disclosed. The customer base spans biotech and pharma R&D teams, hospitals and health systems, contract research organizations, university labs, and innovation and discovery teams, with about 25 named strategic partners (5 hospitals, 12 biotech companies, 8 academic institutions). No funding rounds, investors, or revenue figures are publicly disclosed.

Short descriptiontext

INNOV LABS is an AI-native drug discovery and pharmaceutical R&D platform company offering an Electronic Lab Notebook, multi-omics analysis, and AI-driven scientific reporting for biotech, pharma, hospitals, CROs, and academic research institutions. Headquartered in Texas with a delivery office in India.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCypress, United States
HQ citystring
Cypress
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI drug discovery, electronic lab notebook, pharmaceutical R&D software, multi-omics analysis, biotech research platform
Industry4 codes
PRIMARYHLAGAJAB
Electronic Lab Notebooks (ELN)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Custom Computer Programming Services541511
  • Other Scientific and Technical Consulting Services541690
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Computer Programming Services7371
Product category
AI Drug Discovery Platform
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Platform Subscriptions
TypeSubscription Recurring
Description

Tiered SaaS subscriptions (Research Teams, Growth and Innovation, Enterprise) with advanced features at higher tiers. Cloud-based delivery with compliance controls and API integrations

innovlabs.ai
2Professional Services
TypeProfessional Services
Description

Scientific professional services including Chemical R&D consulting, Biotech & Life Sciences services, Drug Discovery services, Clinical Trial services, ML & AI solutions, and Custom Research & Consultation

innovlabs.ai
3Consulting Engagement Models
TypeProfessional Services
Description

Flexible engagement models including Fractional Scientist Retainer, Project-Based Engagement, Embedded Scientific Team, Expert Review & Advisory, and AI-Augmented Research Support

innovlabs.ai
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details3 tiers
1Research Teams - ELN functionality for academic labs and small research groups
ModelSubscriptionBilling cadenceMonthly
Notes

Electronic Lab Notebook functionality (chemical structures, biological sequences), experiment documentation with secure cloud management, team collaboration tools, onboarding support. Best suited for university labs, research institutes, and early-stage corporate R&D teams.

innovlabs.ai
2Growth and Innovation - For growing biotech and mid-sized R&D teams
ModelSubscriptionBilling cadenceAnnual
Notes

Compliance-ready record management with e-signature workflows and automated version histories, advanced audit trails, collaboration projects and team management with role-based access controls, CRO networking, priority support with dedicated helpdesk. Best suited for biotech startups, CROs, and expanding industrial laboratories.

innovlabs.ai
3Enterprise - For pharma, healthcare, and large-scale R&D corporations
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Advanced compliance controls (Audit-ready data export, ISO & GDPR validation), custom API & instrument integration with LIMS, enterprise-grade governance & SSO (SAML 2.0/Okta), data loss prevention, custom retention policies, flexible deployment architecture (dedicated VPC, secure on-premises/private networks). Best suited for pharma, multinational R&D organizations, and highly regulated clinical environments.

innovlabs.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

INNOV LABS provides an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis using domain-tuned Graph Neural Networks (GNNs) and Transformers, and automated scientific reporting for pharmaceutical, biotech, healthcare, and academic research organizations. The platform is delivered as a tiered SaaS subscription (Research Teams, Growth and Innovation, Enterprise) with 21 CFR Part 11, HIPAA, GDPR, ISO, and SOC 2 compliance. In addition to the platform, INNOV LABS offers professional scientific services covering Drug Discovery & Development, Clinical Trial Scientific Services, Biotech & Life Sciences, Chemical R&D, and ML & AI Solutions delivered through fractional, project-based, and embedded engagement models.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Accelerates drug discovery with lead-ready AI insights
+2 more records
Product overview1 text field

INNOV LABS offers a unified AI-native ELN (Electronic Lab Notebook) platform called Innovlabs.ai, which combines AI, analytics, and documentation for scientific research. The core product portfolio includes the AI Platform for Scientific Data Analysis & Reporting, Electronic Lab Notebook (ELN), Biological Data Analysis Engine, Scientific Reporting & Insights, and Cloud-Based Analytics Platform. These products work together as a cohesive system: the ELN captures structured experiments and protocols, the Biological Data Analysis Engine processes multi-omics data using GNNs and transformers, and the Scientific Reporting module generates publication-ready outputs. In addition to the platform, INNOV LABS provides professional services including Chemical R&D, Biotech & Life Sciences, Drug Discovery & Development, Clinical Trial Scientific Services, and ML & AI Solutions, delivered through various engagement models such as fractional scientist retainers, project-based engagements, embedded scientific teams, and expert reviews.

Product and service8 records
1AI Platform for Scientific Data Analysis & Reporting
CategoryCore AI Platform
Description

A unified cloud platform that combines structured experiment documentation, scalable biological data analysis, and automated reporting, enabling research teams to move from raw data to decision-ready insights in one system. Designed for biotech, pharma, healthcare, and academic research organizations.

2Electronic Lab Notebook (ELN)
CategoryCore AI Platform
Description

A secure, compliant Electronic Lab Notebook for structured experiment capture with AI-assisted documentation, improving reproducibility, traceability, and collaboration. Features 21 CFR Part 11 compliant e-signatures and blockchain integration for IP protection.

3Cloud-Based Analytics Platform
CategoryCloud Infrastructure
Description

High-performance biocomputing with scalable, secure cloud infrastructure supporting petabyte-scale datasets, real-time data processing, and collaborative research with granular access controls.

4Drug Discovery & Development Services
CategoryProfessional Services
Description

Expert scientific consulting for target identification, hit-to-lead and lead optimization, DMPK and ADMET study design, and preclinical program and IND-enabling study management. For pharma and biotech organizations.

5Chemical R&D Services
CategoryProfessional Services
Description

Expert scientific consulting for synthetic route development, compound characterization, process chemistry, and computational chemistry including molecular modeling and QSAR analysis.

6Biotech & Life Sciences Services
CategoryProfessional Services
Description

Biological research design, genomics and sequencing data interpretation, protein science advisory, CRISPR and gene editing program support, and bioprocess development consulting.

7Clinical Trial Scientific Services
CategoryProfessional Services
Description

Clinical protocol design, biomarker strategy and translational science, clinical data review and interim analysis support, and regulatory submission and medical writing.

8ML & AI Solutions
CategoryProfessional Services
Description

Predictive modeling, NLP for bioinformatics, AI-powered drug discovery, genetic data analysis, and custom AI solutions including computer vision for high-content screening and Cryo-EM processing.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

NVIDIA Inception Program member providing AI and deep learning infrastructure capabilities. NVIDIA partnership enables advanced GPU computing for AI model training and inference in drug discovery workflows.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

AI-driven drug discovery company combining high-content screening, computer vision, and machine learning. Partial overlap with Innov Labs' AI-powered drug discovery, multi-omics, and computer vision capabilities.

TypeEmerging player
Description

Scientific data cloud platform that ingests lab instrument data and harmonizes it for analytics and AI. Comparable to Innov Labs in the data platform and LIMS integration layer of its enterprise offering.

TypeDirect peer
Description

Enterprise LIMS and ELN vendor with strong presence in regulated pharma and clinical labs. Directly comparable on ELN functionality and instrument integration available in Innov Labs' Enterprise tier.

TypeEmerging player
Description

Machine learning-driven drug discovery platform focused on predictive modeling for disease and therapeutic response. Comparable to Innov Labs' predictive modeling, multi-omics, and AI drug discovery modules.

5Sapio Sciences
TypeDirect peer
Description

Unified lab informatics platform combining ELN, LIMS, and scientific data management with low-code configuration. Directly comparable on the ELN + LIMS + data platform bundle that Innov Labs packages for enterprise pharma.

TypeDirect peer
Description

Cloud-native R&D platform combining ELN, LIMS, molecular biology, and registry capabilities targeted at biotech and pharma R&D teams. Most direct comparably positioned competitor to Innov Labs' AI-native ELN with structured experiment capture and downstream analysis.

TypeBroad incumbent
Description

Computational chemistry and molecular simulation platform with deep drug-discovery use cases across pharma. Overlaps with Innov Labs on AI/ML-driven lead identification and ADMET prediction for biotech and pharma customers.

TypeBroad incumbent
Description

Life sciences cloud platform spanning clinical, regulatory, quality, and commercial functions for pharma. Adjacent incumbent that touches clinical trial, regulatory, and quality workflows where Innov Labs positions its clinical trial scientific services.

TypeDirect peer
Description

Widely adopted SaaS ELN serving academic and commercial research labs with structured experiment documentation and collaboration. Directly competes in the ELN tier of Innov Labs' offering, particularly for academic and small biotech customers.

TypeBroad incumbent
Description

Enterprise scientific informatics platform offering ELN, LIMS, data management, and analysis for life sciences R&D. Broader incumbent with deeper enterprise footprint; competes directly with Innov Labs in pharma ELN and data capture.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

INNOV LABS

AI Drug Discovery Platforminnovlabs.ai

INNOV LABS is an AI-native drug discovery and pharmaceutical R&D platform company offering an Electronic Lab Notebook, multi-omics analysis, and AI-driven scientific reporting for biotech, pharma, hospitals, CROs, and academic research institutions. Headquartered in Texas with a delivery office in India.

What INNOV LABS does

INNOV LABS is a privately-held AI drug discovery and pharmaceutical R&D technology company headquartered in Houston, Texas, with a secondary office in Hyderabad, India, operating through US entity Innov Labs (Texas) and India entity Innov Labs India (Telangana). The company builds an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis, and automated reporting, powered by domain-tuned Graph Neural Networks and Transformers for multi-omics analysis, predictive modeling, hit-to-lead identification, and ADMET prediction. The platform supports genomics, proteomics, chemistry, and clinical data, with NLP over biomedical literature, computer vision for high-content screening and Cryo-EM, and explainable AI for biological interpretability, all delivered on a cloud-native architecture spanning Azure, AWS, and GCP with deployment options including dedicated VPC and on-premises.

The product portfolio is organized as a unified stack: the AI Platform for Scientific Data Analysis and Reporting, the ELN, the Biological Data Analysis Engine, and Scientific Reporting and Insights. Complementary service lines include Chemical R&D, Biotech and Life Sciences, Drug Discovery and Development, Clinical Trial Scientific Services, and ML and AI Solutions, delivered through fractional scientist retainers, project-based engagements, embedded scientific teams, and expert advisory models. The company maintains HIPAA, GDPR, ISO, and 21 CFR Part 11 compliance, is pursuing AICPA SOC 2 Type 2, and is a member of the NVIDIA Inception Program.

Commercially, INNOV LABS operates a hybrid go-to-market with a sales-led enterprise motion (Request a Demo, Schedule Demo Session, Contact Sales) for pharma, biotech, and healthcare buyers, alongside a product-led growth motion offering a free trial with no credit card required. Pricing is tiered across Research Teams, Growth and Innovation, and Enterprise subscriptions, with billing on monthly, annual, and multi-year cadences; pricing is not publicly disclosed. The customer base spans biotech and pharma R&D teams, hospitals and health systems, contract research organizations, university labs, and innovation and discovery teams, with about 25 named strategic partners (5 hospitals, 12 biotech companies, 8 academic institutions). No funding rounds, investors, or revenue figures are publicly disclosed.

INNOV LABS firmographics

Firmographics
Name
INNOV LABS
Legal name
Innov Labs
Website
https://innovlabs.ai
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
INNOV LABS is an AI-native drug discovery and pharmaceutical R&D platform company offering an Electronic Lab Notebook, multi-omics analysis, and AI-driven scientific reporting for biotech, pharma, hospitals, CROs, and academic research institutions. Headquartered in Texas with a delivery office in India.
Ownership category
akta.pro rank

INNOV LABS industry classification

Industry
Product category
AI Drug Discovery Platform
NAICS
Custom Computer Programming Services (541511), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLAGAJAB
Electronic Lab Notebooks (ELN)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAN
Knowledge Management & Scientific Collaboration / Literature Intelligence
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • AI drug discovery
  • Electronic lab notebook
  • Pharmaceutical R&D software
  • Multi-omics analysis
  • Biotech research platform

Where INNOV LABS is headquartered

Location

Headquarters

HQ city
Cypress
HQ country
United States
HQ region
North America

Offices3 records

Markets served

INNOV LABS business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscriptions: Tiered SaaS subscriptions (Research Teams, Growth and Innovation, Enterprise) with advanced features at higher tiers. Cloud-based delivery with compliance controls and API integrations
  2. Professional Services: Scientific professional services including Chemical R&D consulting, Biotech & Life Sciences services, Drug Discovery services, Clinical Trial services, ML & AI solutions, and Custom Research & Consultation
  3. Consulting Engagement Models: Flexible engagement models including Fractional Scientist Retainer, Project-Based Engagement, Embedded Scientific Team, Expert Review & Advisory, and AI-Augmented Research Support

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyResearch Teams - ELN functionality for academic labs and small research groups
SubscriptionAnnualGrowth and Innovation - For growing biotech and mid-sized R&D teams
SubscriptionMulti-year contractEnterprise - For pharma, healthcare, and large-scale R&D corporations

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

INNOV LABS product offering

Product offering

Core offering

INNOV LABS provides an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis using domain-tuned Graph Neural Networks (GNNs) and Transformers, and automated scientific reporting for pharmaceutical, biotech, healthcare, and academic research organizations. The platform is delivered as a tiered SaaS subscription (Research Teams, Growth and Innovation, Enterprise) with 21 CFR Part 11, HIPAA, GDPR, ISO, and SOC 2 compliance. In addition to the platform, INNOV LABS offers professional scientific services covering Drug Discovery & Development, Clinical Trial Scientific Services, Biotech & Life Sciences, Chemical R&D, and ML & AI Solutions delivered through fractional, project-based, and embedded engagement models.

Product overview

INNOV LABS offers a unified AI-native ELN (Electronic Lab Notebook) platform called Innovlabs.ai, which combines AI, analytics, and documentation for scientific research. The core product portfolio includes the AI Platform for Scientific Data Analysis & Reporting, Electronic Lab Notebook (ELN), Biological Data Analysis Engine, Scientific Reporting & Insights, and Cloud-Based Analytics Platform. These products work together as a cohesive system: the ELN captures structured experiments and protocols, the Biological Data Analysis Engine processes multi-omics data using GNNs and transformers, and the Scientific Reporting module generates publication-ready outputs. In addition to the platform, INNOV LABS provides professional services including Chemical R&D, Biotech & Life Sciences, Drug Discovery & Development, Clinical Trial Scientific Services, and ML & AI Solutions, delivered through various engagement models such as fractional scientist retainers, project-based engagements, embedded scientific teams, and expert reviews.

Differentiator

Problem solved

Functional benefit

Products and services

  • AI Platform for Scientific Data Analysis & Reporting A unified cloud platform that combines structured experiment documentation, scalable biological data analysis, and automated reporting, enabling research teams to move from raw data to decision-ready insights in one system. Designed for biotech, pharma, healthcare, and academic research organizations.
  • Electronic Lab Notebook (ELN) A secure, compliant Electronic Lab Notebook for structured experiment capture with AI-assisted documentation, improving reproducibility, traceability, and collaboration. Features 21 CFR Part 11 compliant e-signatures and blockchain integration for IP protection.
  • Cloud-Based Analytics Platform High-performance biocomputing with scalable, secure cloud infrastructure supporting petabyte-scale datasets, real-time data processing, and collaborative research with granular access controls.
  • Drug Discovery & Development Services Expert scientific consulting for target identification, hit-to-lead and lead optimization, DMPK and ADMET study design, and preclinical program and IND-enabling study management. For pharma and biotech organizations.
  • Chemical R&D Services Expert scientific consulting for synthetic route development, compound characterization, process chemistry, and computational chemistry including molecular modeling and QSAR analysis.
  • Biotech & Life Sciences Services Biological research design, genomics and sequencing data interpretation, protein science advisory, CRISPR and gene editing program support, and bioprocess development consulting.
  • Clinical Trial Scientific Services Clinical protocol design, biomarker strategy and translational science, clinical data review and interim analysis support, and regulatory submission and medical writing.
  • ML & AI Solutions Predictive modeling, NLP for bioinformatics, AI-powered drug discovery, genetic data analysis, and custom AI solutions including computer vision for high-content screening and Cryo-EM processing.

Quantifiable outcome

  • Accelerates drug discovery with lead-ready AI insights
  • +2 more outcomes

Companies that use INNOV LABS

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles5 records

INNOV LABS technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

INNOV LABS partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NVIDIAcoreTechnology or IntegrationNVIDIA Inception Program member providing AI and deep learning infrastructure capabilities. NVIDIA partnership enables advanced GPU computing for AI model training and inference in drug discovery workflows.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

INNOV LABS competitors and assessment

Company assessment

Emerging players

  • Recursion Pharmaceuticals: AI-driven drug discovery company combining high-content screening, computer vision, and machine learning. Partial overlap with Innov Labs' AI-powered drug discovery, multi-omics, and computer vision capabilities.
  • TetraScience: Scientific data cloud platform that ingests lab instrument data and harmonizes it for analytics and AI. Comparable to Innov Labs in the data platform and LIMS integration layer of its enterprise offering.
  • Insitro: Machine learning-driven drug discovery platform focused on predictive modeling for disease and therapeutic response. Comparable to Innov Labs' predictive modeling, multi-omics, and AI drug discovery modules.

Direct peers

  • LabVantage Solutions: Enterprise LIMS and ELN vendor with strong presence in regulated pharma and clinical labs. Directly comparable on ELN functionality and instrument integration available in Innov Labs' Enterprise tier.
  • Sapio Sciences: Unified lab informatics platform combining ELN, LIMS, and scientific data management with low-code configuration. Directly comparable on the ELN + LIMS + data platform bundle that Innov Labs packages for enterprise pharma.
  • Benchling: Cloud-native R&D platform combining ELN, LIMS, molecular biology, and registry capabilities targeted at biotech and pharma R&D teams. Most direct comparably positioned competitor to Innov Labs' AI-native ELN with structured experiment capture and downstream analysis.
  • LabArchives: Widely adopted SaaS ELN serving academic and commercial research labs with structured experiment documentation and collaboration. Directly competes in the ELN tier of Innov Labs' offering, particularly for academic and small biotech customers.

Broad incumbents

  • Schrödinger: Computational chemistry and molecular simulation platform with deep drug-discovery use cases across pharma. Overlaps with Innov Labs on AI/ML-driven lead identification and ADMET prediction for biotech and pharma customers.
  • Veeva Systems: Life sciences cloud platform spanning clinical, regulatory, quality, and commercial functions for pharma. Adjacent incumbent that touches clinical trial, regulatory, and quality workflows where Innov Labs positions its clinical trial scientific services.
  • Dotmatics: Enterprise scientific informatics platform offering ELN, LIMS, data management, and analysis for life sciences R&D. Broader incumbent with deeper enterprise footprint; competes directly with Innov Labs in pharma ELN and data capture.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

INNOV LABS social profiles

Digital presence

INNOV LABS compliance and trust

Trust signal

Compliance5 records

INNOV LABS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

INNOV LABS leadership team

Management profile

Number of profiles

INNOV LABS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

INNOV LABS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INNOV LABS

What does INNOV LABS do?

INNOV LABS provides an AI-native Electronic Lab Notebook (ELN) platform that combines structured experiment documentation, scalable biological data analysis using domain-tuned Graph Neural Networks (GNNs) and Transformers, and automated scientific reporting for pharmaceutical, biotech, healthcare, and academic research organizations. The platform is delivered as a tiered SaaS subscription (Research Teams, Growth and Innovation, Enterprise) with 21 CFR Part 11, HIPAA, GDPR, ISO, and SOC 2 compliance. In addition to the platform, INNOV LABS offers professional scientific services covering Drug Discovery & Development, Clinical Trial Scientific Services, Biotech & Life Sciences, Chemical R&D, and ML & AI Solutions delivered through fractional, project-based, and embedded engagement models.

Is INNOV LABS a public or private company?

INNOV LABS is a private company. It is classified as unknown and is currently operating.

When was INNOV LABS founded?

INNOV LABS was founded in 2024. It employs 11 to 50 people.

Where is INNOV LABS based?

INNOV LABS is headquartered in Cypress, United States, in the North America region.

How does INNOV LABS make money?

Three revenue lines are on record. SaaS Platform Subscriptions are the primary driver. The others are professional Services and consulting Engagement Models.

Who are INNOV LABS's main competitors?

Emerging players on record are Recursion Pharmaceuticals, TetraScience and Insitro. Direct peers are LabVantage Solutions, Sapio Sciences, Benchling and LabArchives. Broad incumbents are Schrödinger, Veeva Systems and Dotmatics.

Does INNOV LABS have an API?

Yes. Custom API and instrument integration is available as part of the Enterprise pricing tier. The platform supports integration with LIMS (Laboratory Information Management Systems) and other enterprise systems using secure APIs and flexible integration frameworks. Available via dedicated Virtual Private Cloud or secure on-premises/private networks deployment options.

What industry is INNOV LABS in?

INNOV LABS's product category is AI Drug Discovery Platform. Its primary akta.pro industry code is HLAGAJAB, Electronic Lab Notebooks (ELN), with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 541511 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales